Hjem › Endometriekreft › Indiana › Indianapolis
Kliniske studier for Endometriekreft i Indianapolis, IN
14 studier for Endometriekreft søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruttererFase 3
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekruttererFase 2
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Saint Catherine Hospital, Indianapolis
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RekruttererFase 2
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Community Health Network, Indianapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RekruttererFase 1
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Riley Hospital for Children, Indianapolis
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- Ascension St. Vicent Hospital, Inc., Indianapolis
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
RekruttererFase 1
- Indiana University, Indianapolis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Community Health Network, Indianapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruttererFase 3
- Research Site, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Community Health Network, Indianapolis
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekruttererFase 1/2
- Community Health Network, Indianapolis
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruttererFase 1/2
- Community Health Network, Inc., Indianapolis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RekruttererFase 2/3
- Indiana University, Indianapolis
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Fedme20 studier
- Brystkreft20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Kardiovaskulær sykdom17 studier
- Lungekreft16 studier
- Type 1-diabetes14 studier
- Alzheimers sykdom14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.